184 related articles for article (PubMed ID: 17675397)
1. Complete cerebral response with sunitinib for metastatic renal cell carcinoma.
Medioni J; Cojocarasu O; Belcaceres JL; Halimi P; Oudard S
Ann Oncol; 2007 Jul; 18(7):1282-3. PubMed ID: 17675397
[No Abstract] [Full Text] [Related]
2. Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib.
Zeng H; Li X; Yao J; Zhu Y; Liu J; Yang Y; Qiang W
Urol Int; 2009; 83(4):482-5. PubMed ID: 19996660
[TBL] [Abstract][Full Text] [Related]
3. Improvement of actinic keratosis associated with sunitinib therapy for metastatic renal cell carcinoma.
Mir-Bonafé JM; Cañueto J; Bravo J; de Unamuno P
Int J Dermatol; 2013 Nov; 52(11):1445-7. PubMed ID: 23432117
[No Abstract] [Full Text] [Related]
4. Targeted Therapy for Renal Cell Carcinoma.
Joshi R; Rawal S
JNMA J Nepal Med Assoc; 2015; 53(198):83-8. PubMed ID: 26994026
[TBL] [Abstract][Full Text] [Related]
5. [Brain metastasis which appeared during complete response of lung metastatic lesion by sunitinib treatment in a patient with renal cell carcinoma].
Morizawa Y; Momose H; Toyoshima Y; Takada S; Fujimoto K; Oyama N
Hinyokika Kiyo; 2013 Dec; 59(12):791-3. PubMed ID: 24419011
[TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report).
Dalhaug A; Haukland E; Nieder C
World J Surg Oncol; 2010 May; 8():36. PubMed ID: 20441600
[TBL] [Abstract][Full Text] [Related]
7. Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.
Aksu G; Ensaroglu F; Dolasik I; Temiz S; Halis H; Sener SY; Kaya A; Uygun K
J BUON; 2010; 15(4):798-9. PubMed ID: 21229650
[No Abstract] [Full Text] [Related]
8. Predictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma.
You D; Song SH; Cho YM; Lee JL; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
World J Urol; 2015 Jan; 33(1):111-8. PubMed ID: 24710685
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib.
Zimmermann K; Schmittel A; Steiner U; Asemissen AM; Knoedler M; Thiel E; Miller K; Keilholz U
Oncology; 2009; 76(5):350-4. PubMed ID: 19321976
[TBL] [Abstract][Full Text] [Related]
10. Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
De Vincenzo F; Zucali PA; Ceresoli GL; Colombo P; Simonelli M; Lorenzi E; Perrino M; Gianoncelli L; De Sanctis R; Graziotti P; Santoro A
J Clin Oncol; 2011 Jun; 29(18):e529-31. PubMed ID: 21483010
[No Abstract] [Full Text] [Related]
11. Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma.
Vaz MA; Pachón V; Grande E; Ferreiro R; Carrato A
Anticancer Drugs; 2011 Sep; 22(8):817-21. PubMed ID: 21566523
[TBL] [Abstract][Full Text] [Related]
12. [PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB].
Namura K; Otake S; Sawada T; Fujikawa A; Ota J; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 2015 Jan; 106(1):30-4. PubMed ID: 26399128
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
Yoshinaga A; Kamata S
Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
[TBL] [Abstract][Full Text] [Related]
14. Editorial comment to "Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: our experience and review of the literature".
Hashimoto H
Int J Urol; 2011 Apr; 18(4):329-30. PubMed ID: 21355893
[No Abstract] [Full Text] [Related]
15. Brain metastases in patients with renal cell cancer receiving new targeted treatment.
Helgason HH; Mallo HA; Droogendijk H; Haanen JG; van der Veldt AA; van den Eertwegh AJ; Boven E
J Clin Oncol; 2008 Jan; 26(1):152-4. PubMed ID: 18165649
[No Abstract] [Full Text] [Related]
16. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
Park CY
Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
[TBL] [Abstract][Full Text] [Related]
17. Metastatic collecting duct carcinoma of the kidney treated with sunitinib.
Tazi EM; Essadi I; Tazi MF; Ahellal Y; M'rabti H; Errihani H
World J Surg Oncol; 2011 Jul; 9():73. PubMed ID: 21752265
[TBL] [Abstract][Full Text] [Related]
18. Intermittent sunitinib for metastatic renal cell carcinoma.
Venkatesan P
Lancet Oncol; 2017 Mar; 18(3):e139. PubMed ID: 28163004
[No Abstract] [Full Text] [Related]
19. Phase III study of sunitinib malate (SU11248) versus interferon-alpha as first-line treatment in patients with metastatic renal cell carcinoma.
Reddy K
Clin Genitourin Cancer; 2006 Jun; 5(1):23-5. PubMed ID: 16859575
[No Abstract] [Full Text] [Related]
20. Outcome of patients with renal cell carcinoma metastatic to the brain treated with sunitinib without local therapy.
Lim ZD; Mahajan A; Weinberg J; Tannir NM
Am J Clin Oncol; 2013 Jun; 36(3):258-60. PubMed ID: 22441343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
